dentalcorp Holdings Ltd header image

dentalcorp Holdings Ltd

DNTL

Equity

ISIN CA24874B1085 / Valor 111405816

Toronto Stock Exchange (2024-09-18)
CAD 8.17-1.80%

dentalcorp Holdings Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Dentalcorp Holdings Ltd is a prominent Canadian company that specializes in acquiring and partnering with leading dental practices across the country. Its business model is centered on providing these practices with a comprehensive range of resources, support, and advanced technology to maintain high standards of oral care. Additionally, Dentalcorp offers continuous education and skill development opportunities for its team members through the DC Institute, ensuring that dental professionals within its network remain at the cutting edge of their field. The company also operates a proprietary online directory, hellodent, which facilitates the connection between patients and Dentalcorp-affiliated dental practices. This platform emphasizes convenience and choice, allowing patients to easily find trusted dental care providers in their local area.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Revenue Growth

Dentalcorp Holdings Ltd. reported revenue of $399.8 million for the second quarter of 2024, marking an 8.6% increase compared to the same period in 2023. This growth was partly driven by a Same Practice Revenue Growth of 2.0%.

Adjusted EBITDA

The company achieved an Adjusted EBITDA of $73.9 million in Q2 2024, which represents a 10.3% increase over the second quarter of 2023. The Adjusted EBITDA Margin also saw an improvement, rising to 18.5%, up by 0.3% from the previous year.

Adjusted Free Cash Flow

Dentalcorp Holdings Ltd. generated an Adjusted Free Cash Flow of $40.7 million in the second quarter of 2024, reflecting a significant 21.1% increase compared to Q2 2023. This contributed to a reduction in leverage levels for the third consecutive quarter.

Practice Acquisitions

During Q2 2024, Dentalcorp Holdings Ltd. acquired nine new practices, which are expected to generate $6.2 million in PF Adjusted EBITDA after rent. These acquisitions were self-funded for the fifth consecutive quarter.

Third Quarter 2024 Outlook

For the third quarter of 2024, Dentalcorp Holdings Ltd. anticipates revenue growth of 8% to 10% compared to Q3 2023, with Same Practice Revenue Growth expected to be between 3.5% and 4.5%. The Adjusted EBITDA Margin is projected to remain consistent with the third quarter of 2023.

Summarized from source with an LLMView Source

Key figures

28.1%1Y
-54.1%3Y
%5Y

Performance

34.5%1Y
41.2%3Y
40.5%5Y

Volatility

Market cap

1108 M

Market cap (USD)

Daily traded volume (Shares)

98,064

Daily traded volume (Shares)

1 day high/low

8.29 / 8.16

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%EUR 52.34
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 35.10
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%EUR 49.35
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.35%EUR 1.74
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.18%SEK 237.80
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%SEK 68.70
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%SEK 170.30
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%SEK 663.00
4basebio PLC
4basebio PLC 4basebio PLC Valor: 112829117
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 17.10
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.13%USD 30.32